Therapeutic Effect of Naloxone on Chronic Obstructive Pulmonary Disease and Type II Respiratory Failure

  • Qingkui Wang
Keywords: Naloxone; Chronic obstructive pulmonary disease; Type II respiratory failure

Abstract

To analyze the efficacy of naloxone in the treatment of chronic obstructive pulmonary disease with type II
respiratory failure. The results of arterial blood gas index in the two groups showed no significant difference
before treatment (P>0.05). The arterial blood gas indexes of the two groups were significantly improved
compared with those before treatment, the difference was statistically significant (P<0.05). After treatment, the
observation group was significantly better than the reference group, and the difference was statistically
significant (P<0.05). The total effective rate of clinical treatment in the reference group was 74.42%, and the
total effective rate of clinical treatment in the observation group was 93.02%. The difference between the groups
was statistically significant (P<0.05). The adverse reactions of the two groups were significantly higher in the
observation group (20.93%) than in the control group (16.28%). There was no significant difference between the
two groups (P>0.05). In the treatment of patients with chronic obstructive pulmonary disease and type II
respiratory failure, naloxone treatment has a quantitative effect, which can effectively improve the arterial blood
gas index, and the clinical effect is more than that of conventional treatment. High, the incidence of adverse
reactions and the conventional treatment methods are not significantly different, the clinical use value is higher,
it is worthy of widespread use and promotion.

Published
2020-05-01